-
ACLA Statement on Updated VALID Act Introduced as Part of Senate FDA User Fee Package
Washington, D.C. – In response to the Senate Committee on Health, Education, Labor and Pensions’ (HELP) release of a bipartisan, updated version of the Verifying Accurate Leading-edge IVCT ... Read More -
ACLA and 15 Leading National Health Care Organizations Urge Extension of COVID-19 Public Health Emergency Declaration
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today joined 15 national health care organizations in a letter to the U.S. Department of Health ... Read More -
ACLA and NACDS, 65 Patient Groups, Provider and Public Health Organizations Urge Congress to Replenish the HRSA COVID-19 Uninsured Relief Fund
WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) and the National Association of Chain Drug Stores (NACDS) today sent a letter with over 60 leading organizations representing patients, ... Read More -
ACLA Statement on Clinical Use of Non-invasive Prenatal Screenings (NIPS)
Washington, D.C. – In response to recent interest in non-invasive prenatal screenings (NIPS) and their use by patients and health care providers, ACLA has issued the ... Read More -
ACLA Statement on the HRSA COVID-19 Uninsured Relief Fund
Washington, D.C. – ACLA issued the following statement in response to delayed Congressional action to replenish the depleted COVID-19 Uninsured Relief Fund: “ACLA is committed ... Read More -
ACLA Announces Susan Van Meter as Next President
Washington, D.C. – ACLA Board Chair William G. Morice, MD, PhD, and President of Mayo Clinic Laboratories, today announced the Board’s selection of Susan Van Meter ... Read More -
ACLA Welcomes Califf Confirmation as FDA Commissioner
WASHINGTON, D.C. – Following the Senate confirmation of Robert Califf, M.D. as Commissioner of the U.S. Food and Drug Administration (FDA), the American Clinical Laboratory ... Read More -
ACLA Statement on COVID-19 Testing Capacity and Turnaround Time
Washington, D.C. – As cases of COVID-19 continue to surge across the country amid the current Omicron wave, ACLA issued the following statement: “Since the outset of ... Read More -
Congress Passes PAMA Relief, Safeguards Seniors’ Access to Critical Lab Tests Ahead of January Deadline
WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) applauds the passage of S. 610, the Protecting Medicare and American Farmers from Sequester Cuts Act, paving the way for renewed ... Read More -
ACLA Applauds Inclusion of PAMA Relief in Year-End Medicare Package
WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) today welcomed the bipartisan and bicameral agreement to safeguard seniors’ access to lifesaving clinical laboratory services in the ... Read More
